Amgen’s medicines treat serious illnesses and typically address diseases with a
limited number of treatment options. With a presence in more than 100 countries,
we are proud to have reached millions of people with our products.
Amgen’s overall mission is to serve patients, which we consider a privilege.
In Australia we market medicines for the treatment of cancer, kidney disease, bone disease and other serious illnesses.
Amgen is committed to providing accurate, up to date and transparent information to patients and their prescribers on all the risks and benefits related to our products. We understand that the ultimate use of the product depends on the individual benefit/risk decision made by patients and their treating physicians.
To access the Product Information or Consumer Medicine Information sheets for Amgen’s products, visit the Our Products page, or contact our Medical Information team for assistance.
You can also contact Amgen Medical Information to ask a question about our products, to report an adverse event (side effect) or product complaint.
Please call 1800 803 638, email: medinfo.JAPAC@amgen.com or visit our website amgenmedinfo.com.au
Our medicines have reached millions of people in the fight against serious illnesses. We focus on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation.
Intended for healthcare professionals, patients, or caregivers in Australia, this site offers scientifically balanced information on Amgen medicines and helps you connect with our Medical Information team.
This portal has been designed to provide Australian healthcare professionals with the latest information and resources to enhance patient outcomes.